2021 Revenues ($USD) : $396,289,000
2021 R&D spend : $52,729,000
2021 Number of Employees : 995
Fiscal Year End : 6/30/2021
Key People : Joshua Levine, CEO; Suzanne Winter, president; Brandon “Brandy" Green, interim CFO; Jean-Philippe Pignol, SVP, chief medical and technology officer; Scott Chapman, SVP, global service; Jesse Chew, SVP, general counsel and corporate secretary; Michael Hoge, SVP, global operations; Patrick Spine, SVP, chief administrative officer; Jim Dennison, SVP, global quality and regulatory affairs

About the company: Accuray develops, manufactures and sells radiotherapy systems as an alternative treatment for cancer. The Sunnyvale, California–based company touts its therapy as a shorter, safer, personalized and more effective way to treat cancer and allow patients to live longer. It is currently developing therapies for breast, intracranial, prostate, lung and head and neck cancers. It has manufacturing facilities throughout the U.S. and China, with regional offices in Hong Kong and Tokyo. –DK